Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Identification of tripeptides against tyrosine kinase domain of EGFR for lung cancer cell inhibition by in silico and in vitro studies.
Chem Biol Drug Des. 2022 Mar;99(3):456-469. doi: 10.1111/cbdd.14010. Epub 2021 Dec 27.
Chem Biol Drug Des. 2022.
PMID: 34923743
A novel cyclic NP1 reveals obstruction of EGFR kinase activity and attenuation of EGFR-driven cell lines.
Jiwacharoenchai N, Tabtimmai L, Kiriwan D, Suwattanasophon C, Seetaha S, Sinthuvanich C, Choowongkomon K.
Jiwacharoenchai N, et al.
J Cell Biochem. 2022 Feb;123(2):248-258. doi: 10.1002/jcb.30160. Epub 2021 Oct 11.
J Cell Biochem. 2022.
PMID: 34633106
Item in Clipboard
The Effect of the EGFR - Targeting Compound 3-[(4-Phenylpyrimidin-2-yl) Amino] Benzene-1-Sulfonamide (13f) against Cholangiocarcinoma Cell Lines.
Samatiwat P, Tabtimmai L, Suphakun P, Jiwacharoenchai N, Toviwek B, Kukongviriyapan V, Gleeson MP, Choowongkomon K.
Samatiwat P, et al. Among authors: jiwacharoenchai n.
Asian Pac J Cancer Prev. 2021 Feb 1;22(2):381-390. doi: 10.31557/APJCP.2021.22.2.381.
Asian Pac J Cancer Prev. 2021.
PMID: 33639651
Free PMC article.
Item in Clipboard
Discovery of potent antiproliferative agents from selected oxygen heterocycles as EGFR tyrosine kinase inhibitors from the U.S. National Cancer Institute database by in silico screening and bioactivity evaluation.
Jiwacharoenchai N, Saruengkhanphasit R, Niwetmarin W, Seetaha S, Choowongkomon K, Ruchirawat S, Eurtivong C.
Jiwacharoenchai N, et al.
Bioorg Med Chem Lett. 2022 Feb 15;58:128524. doi: 10.1016/j.bmcl.2021.128524. Epub 2022 Jan 4.
Bioorg Med Chem Lett. 2022.
PMID: 34995690
Item in Clipboard
Cite
Cite